Professional Documents
Culture Documents
Drug Design Workshops
Drug Design Workshops
Faculty of Pharmacy
September 2021
Background
Computer-aided drug design (CADD) approaches can use the information in the 3D
structures of biological target molecules to identify chemicals with a high potential for
binding to these target molecules. The selected compounds are referred to as lead
compounds and may then be subjected to additional structural optimization via structural
biology, CADD and novel organic synthetic methods to obtain compounds with improved
activities. Both the lead compounds and their optimized analogs represent chemical entities
with a high probability of being developed into therapeutic agents and, therefore, are of
great interest to pharmaceutical companies.
Overview
The specific training areas could cover the following:
1. Finding potential enzyme inhibitors using computational drug design techniques such
as:
a. Molecular docking and molecular dynamics
To study the 3D molecular recognition between small molecules and target enzymes
in order to understand the best fitting between them via analysis of the energetics
of binding and investigation of drug-receptor interactions.
b. Structure activity relationships (SAR) and Quantitative structure activity
relationships (QSAR)
To study the relationships between the molecular structure (functional groups and
substituents) and the activity of the compounds, and to quantify the effects of these
functions via building statistical models that allow the prediction of biological
activities of suggested compounds, using specific software designed carefully for this
purpose.
2. Prediction of physicochemical ADMET (Absorption, distribution, metabolism, excretion
and toxicity) properties of chemical compounds.
(II) Practical
All Tutorials will be conducted using Molecular Operating Environment (MOE) package.